Despite COVID-19 incident last year, the domestic obesity treatment market set a new record. the market sales of Qsymia and Saxenda, which is known for injectables to lose weight, expanded to the highest level ever.
According to IQVIA on the 23rd, the domestic market for obesity treatments last year was ₩143 billion. It has achieved the largest scale ever, increasing 6.6% from the previous year. Compared to ₩96.8 billion in 2018, this is an increase of 47.7% in two years.

Belviq (Lorcaserin), which had formed annual sales of ₩10 billion, was withdrawn due to safety issues at the end of 2019 and suffered a global recession due to COVID-19, but it recorded a new record in sales for t